Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...